The Latest Breaking News from Pfizer

U.S. regulators have approved the first RSV vaccine for pregnant women to protect their newborns

The Food and Drug Administration has approved the first vaccine for expectant mothers to shield their babies from RSV.

Maybe it's not a full-blown summer surge but COVID numbers are ticking up. For those with concerns due to personal risk factors or the start of the school year, the booster question is top of mind.

A new method called ‘skeletal editing’ offers a hugely simplified way to alter matter, paving the way for world-changing innovations in personalised medicine and sustainable plastics

The pharma industry is poised to witness long-term growth with the introduction of generic medicines and growing demand for personalized and targeted treatments. Hence, fundamentally strong pharma stock AbbVie (ABBV) might be worth buying. However, it might not be the right time to invest in Pfizer (PFE). Keep reading.

A panel of U.S. health advisers is recommending that babies get a new drug to protect them against a respiratory virus

The biggest names in Covid are updating their vaccines for a fall campaign, but that might not bolster Pfizer stock and Moderna stock.

Pfizer stock wavered early Tuesday after the company reported massive sales and earnings declines amid lower demand for Covid products.

Medical journals describe all-cause mortality in randomized controlled trials (RCTs)